by LMC Healthcare | Oct 21, 2016 | News
LMC’s telemedicine service is dedicated to the provision of medical consultation and follow-up services for Diabetes & Endocrine conditions to individuals over the age of 18 living in the various LHIN’s. We have recently begun accepting referrals from...
by LMC Healthcare | Aug 17, 2016 | News
Sanofi announced on July 28th that the U.S. Food and Drug Administration (FDA) approved AdlyxinTM (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes. “The...
by LMC Healthcare | Jun 10, 2016 | News
Collaboration Brings Together Leading U.S. Metabolism-Focused CRO and Largest Canadian Diabetes Site Network SAN DIEGO AND TORONTO, June 10, 2016 /PRNewswire/ – Profil Institute for Clinical Research, a science-driven clinical research organization (CRO) focused...
